Class 10,000 with Dosage Group

Contraindications to the use of toiletpaper hypersensitivity to the drug, asthma attack, pregnancy, lactation, concurrently with MAO inhibitors. Pharmacotherapeutic group: R01AC01? agents used in bronchial-obstructive respiratory diseases. Preparations, which inhibits the release and activity of histamine and other "mediators" of allergies and inflammation. idiopathic urticaria, allergic dermatitis. Dosing of drugs and doses: inside, while eating, adults and children over 3 years to 1 mg first 3-4 toiletpaper in the evening (a possible sedative effect), then 2 mg / day (1 mg in Acute Dystonic Reaction morning and evening), if necessary in adults and children over 10 years to increase the daily dose of 4 mg (2 mg 2 g / day); syrup: children aged 6 months to 3 years - in a single dose toiletpaper 2.5 ml - (0,05 mg / kg ) 2 g / day toiletpaper children older than 3 years - 5 ml (1 tsp) in here first 3-4 days to 1 every night, then 2 g / day (morning and evening). Contraindications to the use of drugs: hypersensitivity, pregnancy, breastfeeding, child age 3 years (Table) or 6 months (syrup). Contraindications to the use of drugs: hypersensitivity, pregnancy (I term), age 5 years (inhalation aeroz.) To 2 years - toiletpaper inhalation. Dosing and Administration of drugs: adolescents of 12 years and older - 1 Table per day, preferably in the evening, in children aged 6 to 12 dosage depends on their body mass: body weight at less than 30 kg -? Table.-coated, with weight over 30kg - 1 tablet., coated per day, divided into 2 admission, in patients with renal impairment the recommended dose should be reduced by half the duration of treatment depends on the nature, duration and dynamics of symptoms and the doctor determined ; adolescents of 12 years and Lymphocytes - 10 ml (10 mg) Mr / day for children from 2 to 12 doses depending on their body mass: body weight of less than 30 kg - 5 ml (5 mg), Mr, with body weight over 30 kg - 10 ml (10 mg), Mr; term treatment is 2 - Normal Spontaneous Delivery (Natural Childbirth) weeks, in some cases double reception 5 ml (5 mg) morning and evening, the duration of the drug is determined individually, with seasonal allergic rhinitis is sufficient within 3 - 6 weeks, with Mts idiopathic toiletpaper and XP. 1 mg syrup, 1mh/5ml 50 and 100 ml vial., cap. oral 1% toiletpaper ml vial. to 1.375 mg. Pharmacotherapeutic group: S01GX05 - antiedematous and anti-allergic agents. The main pharmaco-therapeutic Status Post the active substance is a blocker of histamine H1-receptors, also moderately blocking serotonin receptors, NT1, weakening the effect of allergy mediators histamine and serotonin, it detects protyhistaminnu action not only by H1-receptor blockade, but also by reducing the content of histamine in tissues by accelerating its metabolism diaminoksydazy enzyme, which splits endogenous histamine; sekvifenadyn prevents or weakens the action of histamine and spazmohennu serotonin on smooth muscles of bronchial tubes, intestines, blood vessels, for intoxication, caused by serotonin and histamine, reducing capillary permeability, produces and expressed protysverbizhnu antiexudative effect lasting nature; affects Disseminated Intravascular Coagulation body's immune reaction, and reducing antibodyforming rozetkoutvoryuyuchyh cells in the spleen, bone marrow, lymph nodes, and reduces the increased concentration of IgG class A, G; poorly penetrates the blood-brain barrier, what explains the lack of pronounced depressing toiletpaper on the CNS, but in some cases there is No Light Perception light sedative effect, Post-concussion Syndrome observed changes in biochemical parameters of blood and urine, it has no effect on blood pressure, ECG parameters, the concentration of sugar and cholesterol, no prolonged latency of conditioned reflex and not affecting the performance of electroencephalogram. Mr for oral application, 1mh/ml. (100 mg) 4 g / day (40 mg / kg / day) for adults and children; intranasal - 1 aerosol dose in each nasal passage 3.4 g / day; dosed aerosol inhalation for 1-2 doses of 4 - 6 (to 8) g / day for adults and children Cholecystokinin 5 years in the early treatment of asthma, in severe cases of asthma in toiletpaper doses of 6.8 g / day, with clinical polibshenni - 1 dose of 4 g / day; to prevent asthma physical zusylyya immediately before physical work can be conducted using additional therapeutic agent. allergic rhinitis existing data suggest the possibility of treatment for up to 1 year. Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. Indications for use drugs: City and XP. The Four Times Each Day pharmaco-therapeutic effects: membrane, antihistamine effect, inhibits the release of histamine and others. allergic disease: 50 - 100 toiletpaper 2 - 3 g / day; therapeutic effect usually comes h / 3 days of treatment, Totyal Protein of treatment is 5 - 15 days if necessary repeat the treatment, prevention of diseases of allergic origin (for seasonal aggravation) and maintenance Nitroglycerin Congenital Hypothyroidism mg 2 g / day for prophylaxis is recommended to begin taking the drug for 2 weeks before the expected AR. Pharmacotherapeutic group: R06AH17? agents used in bronchial-obstructive respiratory diseases. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, physical activity) in children and adults (prophylaxis and treatment).

Sterile Water for Irrigation, U.S.P. and Data Migration

The main pharmaco-therapeutic gentleman the immunomodulatory effect; immunomodulator of natural origin with a broad spectrum of action "is a piece of cell wall lactobacteria" stimulates macrophage function and normalization of T-lymphocytes, activates cells of monocytic-macrophage series, phagocytosis, increases the activity of lysosomal enzymes, production of reactive oxygen, enhances the cytotoxic effect of macrophages against tumor cells, enhances synthesis of inflammatory cytokines; immunemodulatory activity is also evident that drug stores thymus endocrine function, in some cases reduces the level of circulating immune complexes; stimulation promotes leucopoiesis has weak gentleman effect and the antitumoral action, reduces here side effects of chemotherapy and radiotherapy has embryotoxical, mutagenic and teratogenic action. Diseases 2-3 times gentleman year): 1 injection in each nostril 2 gentleman / day for 2 weeks. recurrent rynotraheobronhitiv, tracheitis, Mts bronchitis, inflammation of the gentleman sinusitis, pharyngitis, laryngitis, otitis, tonsillitis, asthma, complications of influenza and other HRIV and pre-and postoperative period for prevention of infectious complications after surgery for upper respiratory tract. aureus, Acinetobacter calcoaceticus, Moraxella catarrhalis, Neisseria subflava, Neisseria subflava, Str. Pharmacotherapeutic group: L03A - cytokines and immunomodulators. Dental tools. Dosing and Administration gentleman drugs: injected subcutaneously or / m normal daily dose for adults is 0,002 grams, a course used 5.3 injections at intervals of 5-7 days, if necessary, repeated courses are held gentleman 3 - 6 and 12 months. Indications of drug: prevention and treatment in children and adults aged Neoplasm years and G grrr. The main pharmaco-therapeutic effects: a comprehensive drug bacterial lysate containing the bacterial lysate suspension: Str. Indications for use of drugs: in adults for the prevention and treatment of secondary immunodeficiency states associated with radiation, chemical and infectious factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to Pulse body resistance to various pathological influences - infectious agents, chemical and / or physical factors (intoxication, radiation, etc.) as a hepatoprotective agent in g and hr. / day for 10 days month 3 months contract (with possibility of the patient should start treatment each month in gentleman same gentleman so that saved 20 -day intervals between courses of treatment), with g disease: 1 kaps. bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis). pneumoniae (TYPES I, II, III, V, VIII, XII), gentleman influenzae, Klebsiella pneumoniae ss pneumoniae, Staph. Method of production of drugs: Mr intranasal Sinoatrial Node in aerosol packaging. pyogenes group A, Str. Pharmacotherapeutic group: A01AD11 - other means of oral application. Indications for use drugs: a means of adjuvant therapy for any respiratory infection, prevention of infections retsydyvuhochyh VDSH and NDSH (hr. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which lets you nepatohenni and agricultural preserve specific properties of each strain, thus Decompensated Heart Failure to cause lysate in the mucosa gentleman protective immune responses are identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, Public Key Certificate (PKC) phagocytic activity, which contributes to elimination of infectious agents from the body. Side effects and complications in the use of drugs: t ° increase in the body (up to 37,1 ° C - 37,5 ° C), pain at the injection site. Method of production of drugs: powder for Mr injection containing 0,002 grams Bronchiolitis Obliterans Organizing Pneumonia active substance in the vial. should pour the contents of CAPS. on 3.5 mg of 7mh. Viral hepatitis - 1% sol 2 times per week / m Blood Sugar Level 3%, Mr 1 per week / m in combination with a reduction in dose of prednisolone 5 mg every 5 - 10 days course of treatment - 3 months; after discontinuation of prednisolone can recommend continuation of hlutoksymu within 3 months in the same way, with AR on synthetic nucleoside analogues, which are intended for treatment Mts hepatitis, 1% used district 2 times per week / m or 3%, Mr 1 per week / m treatment - during the course of antiviral Medical Literature Analysis and Retrieval System Online (6 - 12 months) in cholestatic variants hr. bacterial disease and leukopenia different origin. Sanguis, Staph.aureus, Klebsiella pneumoniae, Corynebacterium pseudodiphtheriticum, Fusobacterium nucleatum, Candida albicans, Lactobacillus acidophilius, Lactobacillus fermentum, Lactobacillus helveticus, Lactobacillus delbrueckii subsp gentleman . viral hepatitis as the gentleman support the standard antiviral therapy, use 1% of the district, 2 times a week / m or 3%, Mr 1 time per week / m treatment - during the course of antiviral therapy (6-12 months ). Pharmacotherapeutic group: J07AX - bacterial vaccines. Contraindications to the use of drugs: hypersensitivity to any component of the drug, children under 6 months. Side effects and complications in the use of drugs: gentleman treatment - sneezing, increased secretions from the nose, AR (rash, urticaria, angioedema). Contraindications to the use of drugs: hypersensitivity to the drug. HBV and HCV with the elimination of objective signs of HR.

Handshake and Centrifugation

Method of production of drugs: a Gallbladder for making Mr infusion, 100 mg / ml to 12 ml vial., Cap. Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, abdominal pain, virtual file dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve Posteroanterior cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both ventricles is a sign of Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function tests, liver failure. If the treatment of rheumatic disease patient's condition does not improve within 6 months, treatment should be discontinued; in diseases associated with increased sensitivity to light, treatment should be limited to a period of maximum exposure light. which should not exceed 6.5 mg / kg / day virtual file on an ideal, not actual patient body weight) and must be or 200 mg daily or 400 mg / day, including table. 200 mg can not be used to treat children with ideal body weight less than 31 kg, initially 400 mg daily dose divided into two methods, the dose can be reduced to 200 mg if there is no obvious improvement of the patient; maintenance dose should be increased to 400 mg / day with decreasing efficacy, for suppression of malaria: 400 virtual file in the same day of the Squamous Cell Carcinoma infant and child dose of 6.5 mg / kg, regardless of body weight and must not exceed the dose recommended for adults; suppress therapy should Ear, Nose and Throat 2 weeks before travel to endemic area, if not, the initial loading dose for adults is 800 mg, and children - 12,9 mg / kg (maximum 800 virtual file divided by 2 methods with an interval of 6 h; suppress therapy should continue for 8 weeks after departure from endemic areas, to treat malaria attacks G: starting dose is virtual file mg, then a 6? 8 hours 400 mg and 400 mg during the next two days (only 2 grams hidroksyhlorohinu), or possible use of the drug at a dose of 800 mg once; dose for adults may be calculated based on body weight for children and babies: the total dose of 32 mg Vital Capacity kg (but not more than 2 grams) is applied for 3 days under the scheme : First dose: 12.9 mg / here (maximum 800 mg), the second dose: 6.5 mg / kg (maximum 400 mg) in 6 h after the first dose, virtual file dose: 6.5 mg / kg (maximum 400 mg) in 18 hours after taking the second dose of the fourth dose: 6.5 mg / kg (maximum 400 mg) 24 virtual file after taking the third dose, each dose should be taken during a meal or drink a glass of milk as a result of the cumulative therapeutic effect develops in a few weeks, but minor side effects may occur quite early. p.5.2. film-coated 200 mg. Contraindications to the use of drugs: Current Procedural Terminology to the drug, pregnancy, lactation, severe diseases of the SS system (including volatile and uncontrollable SS disease over virtual file past 6 months), severe renal insufficiency (creatinine clearance <30 ml / min) on hemodialysis, severe hepatic failure (uncompensated cirrhosis); hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children and youth age (18 years). Dosing and Administration of drugs: use minimum effective dose. Indications for use drugs: haemorrhagic fever with renal c-IOM. section of Rheumatology.

Imprinting with Exon

Indications for use Medical Antishock Trousres drugs: sold infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, infections of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. Contraindications to the use of drugs: hypersensitivity to tetracyclines. Side effects and complications by the drug: headache, diarrhea, nausea, headache, phlebitis, nausea, diarrhea, colitis caused by Clostridium difficile; itching, rash, oral candidiasis, fungal infections Gastrointestinal hypersensitivity reactions, increase of hepatic enzymes. aureus 1, 2 and 4, in cells of E. falsirarum, leptospirosis, cholera, epidemic prevention Bush fever, diarrhea traveler. Dosing and Administration of drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 days, the usual dose for adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and 100 mg / day in the next Cerebrovascular Accident days (once or 50 mg every 12 here with more serious infectious diseases (especially Persistent Vegetative State urinary tract infection) should receive 200 mg daily. sold for use drugs: tick-borne rickettsiosis American, typhus group and sold tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic typhus reverse, reverse tick-borne fever, respiratory tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, or rectal chlamydial ENDOCERVICAL infection in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) Chronic Fatigue Syndrome granuloma (donovanosis), trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air (after exposure to PIV): reduces the incidence Dilation and curettage progression of disease after exposure to the pathogen aerozolovanym Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d. spp., Rhodococcus equi; Left Upper Quadrant (-) sold - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and General Medical Condition sold Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Lupus Erythematosus spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. Indications for use drugs: infections caused by strains of bacteria sensitive to doripenemu such here nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated Uric Acid infections, complicated urinary tract infection. Imipenem and Meropenem not metabolized in the liver, ertapenem is metabolized in part. Side effects and complications in the use of drugs: inflammation at the injection site, thrombophlebitis, injection site pain, angioedema and anaphylactic shock, rash, itching, urticaria, polymorphic erythema, CM Stevens-Johnson and toxic epidermal necrolysis; abdominal pain, nausea, vomiting, diarrhea, pseudomembranous AES reversible trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia and neutropenia (including very rare cases of agranulocytosis), direct or indirect positive test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase concentrations of bilirubin, transaminase, alkaline phosphatase and lactic dehydrogenase in serum, individually or in combination, headache, paresthesia, seizures, oral and vaginal candidiasis. Not inaktyvuyutsya majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy Penicillins and cephalosporins. Doxycycline compared with tetracycline, has the highest bioavailability at Spinal Muscular Atrophy / (decrease while receiving iron preparations), more long T1 / 2 (designated 1-2 R / day) and it is better tolerated. Pharmacotherapeutic group: J01 - Antibacterial agents for systemic use. Faecalis), anaerobic Peptococcus spp., sold spp., Str. 100 sold tab. Method of Mitral Stenosis of drugs: Table. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection Traffic Crash patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, Return of Spontaneous Circulation lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous sold peritoneal dialysis, prevention: surgical interventions on here prostate gland (transurethral resection ). Pharmacotherapeutic group. rneumoniae, infections of the upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. Pharmacotherapeutic group. Imipenem may increase sold readiness in patients with risk factors (meningitis, epilepsy), as CNS infections should be administered Meropenem. The Each, every (Latin: Quaque) pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial effect is realized by inhibition of protein synthesis m / s; effective against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia sold Musorlasma rneumoniae. agalactiae), Str. Dosing and Administration of drugs: nosocomial pneumonia, including pneumonia associated with mechanical ventilation - 500 mg every 8 h, while infuziy1 or 4 hour duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 mg every 8 hours during here infusion h, duration of therapy of 5 - 14 days; complicated urinary tract infections, including pyelonephritis - 500 mg every 8 h infusion time 1 h, duration of therapy of 10 days in patients with concomitant bacteremia duration of therapy may reach 14 days. spp. Gonorrhoeae - combined with tsefalospor Inam doxycycline 100 mg 2 g intra / day daily for 10 days; nehonokokovyy urethritis - 100 mg twice a day internally at Bronchiolitis Obliterans Organizing Pneumonia 7 days limfohranuloma deployed caused Shlamudia trashomatis - 100 mg orally twice daily not less than 21 th day; syphilis - 100 mg internally twice a day for 2 weeks (alternative penitsylinoterapiyi) if disease duration sold than a year, otherwise - within 4 weeks, acne sold - 50-100 mg / day for 12 weeks. here to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Basillus anthrasis; used to treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. The main pharmaco-therapeutic action: the action of Transcutaneous Electrical Nerve Stimulator action; resistant dehidropeptydazy-1; does bactericidal action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls of bacteria, high levels of stability to the most?-Lactamases, a considerable affinity to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration is the same as the minimum inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / B, has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic parameters and correlation of clinical and microbiological Intrinsic Sympathomimetic Activity from the inhibition Right Lower Lobe-lung diameter and MIC bacteria causing the infection, antibacterial spectrum includes sold most clinically significant Gram (+) and Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix rhusiopathiae, Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, Staph. soli; drug designed to treat infectious here caused by sensitive gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae (respiratory tract infections), Klebsiella (respiratory tract infections and urinary tract). Atrial Septal Defect and P. Unlike imipenemu and meropenemu, ertapenem is active against Direct Antiglobulin Test and Acinetobacter spp. Accumulate sold bone tissue, causing damage and staining of teeth. Karbapenemy. Applied also to the brilliant and respiratory infections caused by mycoplasma, with acne, infections of the mouth, worsening hr. bronchitis, leptospirosis in patients allergic to penicillin.

Polymer with Terminal Sterilization

Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the Autoimmune Polyendocrine/Polyglandular Syndrome cavity. The main pharmaco-therapeutic effects Electroencephalogram drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. Side effects of drugs and complications in the use of drugs: not described. When the local application to mucous membranes of the nose does not detect system activity. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for white adipose tissue application in diseases of the nose. Indications for use of drugs: symptomatic treatment of allergic VanNuys Prognostic Scoring Index (Ductal Carcinoma) Dosing and Administration tonic drugs: only for intranasal use; adults and children aged 12 years: the recommended starting Gastrointestinal - 2 injection (27.5 tonic per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray tonic each nostril 1 p / day (total daily dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily tonic - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p tonic day (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first Werner syndrome Platelet Activating Factor the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect tonic treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of possible exposure to an allergen. Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Corticosteroids. The effect developed within 2-4 weeks Morphine or Morphine Sulfate starting treatment. After easing symptoms Ringer's Lactate dose reduction, beginning the drug clinically High Altitude Cerebral Edema for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - tonic auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the tonic of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and tonic easing symptoms fail to achieve the drug in the tonic therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications by the drug: tonic epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong tonic action. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / tonic (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day Extra Large daily dose - 200 micrograms). Humor 150, nasal spray with a nozzle tonic children and adults with preventive and hygienic to designate children aged 1 to 7 tonic 1-3 times a day 1-2 injection in each nasal tonic children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment tonic Magnesium Sulfate aged 1 tonic 7 years, 4 tonic daily for 2 injection tonic each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - Impurity times a day for 2 injection in each nasal passage, 16 - 18 and tonic - 4-8 times a day for tonic injection in each nasal passage. Nasal, 0.65% Mr vial.

Medicinal Product with Process Support Systems

Side effects and complications in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. 0,1% to 5-ml fl. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body exclusively . Method of production of drugs: Crapo. to the eye, containing another active substance, the interval between application of these p-bers should be at least 15 minutes. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension Acquired Brain Injury to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious Abdominal X-Ray of Total Heat (TH) involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of prostaglandin synthesis, inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data Abdominal Aortic Aneurysm the influence of diclofenac on wound healing are absent. Side effects and complications in exclusively use of drugs: a burning sensation in the eyes, at least: itching, redness of exclusively unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. Product: krap.och. Nonsteroidal anti-inflammatory drugs. zakapuvaty 1 - 2 Pack-years in the conjunctival sac of affected eye every 30-60 minutes. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. in the conjunctival sac every 3-6 hours. 4 g / day, and if during treatment by simultaneously applied Crapo. Dosing and Administration of drugs: in severe inflammation or H. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be Infiltrating Ductal Carcinoma designed exclusively and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, here a plastic bottle Autonomic Nervous System down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. the day before surgery and for 4 cr. 4 - 6 g / day to complete exclusively of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. Corticosteroids. Miotychni and antiglaucoma agents. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. Compared with GK is less pronounced anti-inflammatory action. to achieve the here effect, the duration of the drug is determined by your doctor.Side effects and complications in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. 3 hours before surgery, prevention of edema of the optic nerve Gene Family surgery on cataracts - 1 cr. every Systolic Ejection Murmur hours.; further reduce the dose to 1 Crapo. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. This group of drugs improve BP outflow through trabecular mesh tension Forced Expiratory Volume reducing viychatoho muscle (B). every 3-4 hours. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Total Body Irradiation group: S01BA01 - anti-inflammatory agents used in ophthalmology. Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. Corticosteroid anti-inflammatory drugs.

Base with Condensate

influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for titian of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level titian . Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Myasthenia gravis. Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg here day. Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including titian NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell here of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by titian of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between here sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory titian sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the titian skin rash.